Similarly, CD93 (cg14928764) marks leukemic stem cells in MLL-rearranged AML and a therapy-resistant quiescent population in CML, while its inhibition reduces AML proliferation22–24. Here, KMT2A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.